Risks of fatal cancer from inhalation of 239,240plutonium by humans: A combined four-method approach with uncertainty evaluation

Health Physics

Volumn 80, Issue 5, 2001, Pages 447-461

  Grogan, H A ^a   Sinclair, W K ^a   Voilleque P G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLUTONIUM 239; PLUTONIUM 240;

ADULT; AGE; AGED; ALPHA RADIATION; ARTICLE; BONE CANCER; BONE MARROW CANCER; CANCER RISK; FEMALE; HUMAN; LINEAR ENERGY TRANSFER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RELATIVE BIOLOGIC EFFECTIVENESS; RISK ASSESSMENT;

ANIMALIA;

EID: 0035075907     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200105000-00005     Document Type: Article

References (65)

1. Primary liver tumors among Danish patients exposed to Thorotrast
2. Experimental studies in mice on the late effects of radioactive and nonradioactive contrast media
3. Leukemia risk in Thorotrast patients
4. A proportional hazards analysis of bone sarcoma rates in German radium-224 patients
5. Cancer risk coefficients for environmental exposure to radionuclides
6. Estimating radiogenic cancer risks
7. Estimating radiogenic cancer risks. Addendum: Uncertainty analysis
8. Radium in man
9. Time-related factors in the study of risks in animals and humans
10. 2
11. Technical summary report for the historical public exposures studies for Rocky Flats phase II
12. Assessing risks of exposure to plutonium
13. 3
14. Lung cancer in radiochemical industry workers
15. Alpha radiation risk coefficients for liver cancer, bone sarcomas, and leukemia
16. Biological effects of inhaled radionuclides
17. 1990 Recommendations of the International Commission on Radiological Protection
18. Age-dependent doses to members of the public from intake of radionuclides: Part 2, ingestion dose coefficients
19. Human respiratory tract model for radiological protection
20. Age-dependent doses to members of the public from intake of radionuclides: Part 4, inhalation dose coefficients
21. Estimated absorbed doses in tissues and radiation effects in Japanese Thorotrast patients
22. Tissue dose in Thorotrast patients
23. The risk of cancer among nuclear workers at the "Mayak" production association: Preliminary results of an epidemiological study
24. Lung cancer risk due to exposure to incorporated plutonium
25. 239Pu as young adults
26. 239Pu and some other internal emitters for bone cancer induction in beagles
27. 239Pu
28. 226Ra
29. Risk estimates for liver
30. Bone sarcoma incidence vs. alpha particle dose
31. Bone tumors in Thorotrast patients
32. Toxicity ratios: Their use and abuse in predicting the risk from induced cancer. Life-span radiation effects studies in animals: What can they tell us?
33. Bone sarcoma induction by radium 224 in C57BL/Do mice
34. Data on lung cancer deaths in Colorado, 1988-1997
35. 224Ra and Thorotrast
36. 224Ra injected into dogs
37. Toxicity of inhaled plutonium dioxide in beagle dogs
38. Uncertainties in fatal cancer risk estimates used in radiation protection
39. Studies of the mortality of atomic bomb survivors. Report 12: Part I. Cancer: 1950-1990
40. Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987
41. Bone cancer risk estimates
42. 90Sr
43. Three-dimensional models of risk from internally deposited radionuclides
44. Distribution of inhaled plutonium in rat and hamster lung
45. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality
46. 2
47. 2 in rats
48. Lung tumor response to inhaled plutonium and its implications for radiation protection
49. 2 aerosol. III. Survival and lung tumors
50. Risk estimates for bone
51. Science, radiation protection and the NCRP. Lauriston S. Taylor Lectures in radiation protection and measurements
52. Mortality of workers at the Sellafield plant of British Nuclear Fuels
53. Leukemia incidence in the U.S. dial workers
54. 241Am and Thorotrast in the grasshopper mouse. Onchomys leukogaster
55. The US radium luminisers: A case for a policy of 'below regulatory concern
56. Plutonium and lung cancer
57. Multifactorial analysis of lung cancer dose-response relationships for workers at the Mayak nuclear enterprise
58. Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or γ rays
59. A 42-year medical follow-up of Manhattan Project plutonium workers
60. Mortality through 1990 among white male workers at Los Alamos National Laboratory: Considering exposures to plutonium and external ionizing radiation
61. Mortality among plutonium and other radiation workers at a plutonium weapons facility